Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action.

Source:http://linkedlifedata.com/resource/pubmed/id/9178844

Neurosci. Lett. 1997 May 9 227 1 1-4

Download in:

View as

General Info

PMID
9178844